UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the Month of November 2022

Commission File Number: 001-39810

IDEX Biometrics ASA

(Translation of registrant’s name into English)

Dronning Eufemias gate 16

Oslo, Norway

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: ☒ Form 20-F ☐ Form 40-F

INCORPORATION BY REFERENCE

This Report on Form 6-K and Exhibits 99.1 and 99.2 to this Report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form F-3 (File No. 333-250186) and registration statements on Form S-8 (File Nos. 333-254083, 333-259210 and 333-265481) of IDEX Biometrics ASA (including any prospectuses forming a part of such registration statements) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

~~Unregistered~~Other ~~Sales~~Events ~~of Equity Securities~~

~~On November 16, 2022,~~ IDEX Biometrics ASA (the “Company”) ~~announced~~distributed a ~~contemplated~~notice ~~private placement~~ of ~~new~~an ~~shares~~extraordinary ingeneral ~~the~~meeting ~~Company.~~(“EGM ~~The~~Notice”), ~~press~~which ~~release~~includes ~~announcing~~a ~~the~~form ~~contemplated~~of ~~placement~~proxy is(“Form ~~attached~~of toProxy”), ~~this Report~~ on ~~Form~~November 18, ~~6-K~~2022, as ~~Exhibit~~updated 99on November 21, 2022.1.

OnThe ~~November 16,~~EGM ~~2022,~~Notice ~~the~~is ~~Company~~furnished ~~announced~~herewith ~~the~~as ~~successful~~Exhibit ~~completion of the aforementioned private placement~~99.1 ~~The press release announcing the completion of the placement is attached~~ to this Report on Form 6-K ~~as Exhibit 99~~.2.

~~Disclaimer~~The information contained in this Report on Form 6-K and Exhibit 99.1 to this Report on Form 6-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any filing under the Securities Act of 1933, as amended, unless expressly set forth by specific reference in such a filing.

This Report on Form 6-K, including the exhibits hereto, is not an offer of securities for sale in the United States. The securities referred to in this Report on Form 6-K, including the exhibits hereto, have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and accordingly may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and in accordance with applicable U.S. state securities laws. The Company does not intend to register any part of the offering or their securities in the United States or to conduct a public offering of securities in the United States. Any sale in the United States of the securities mentioned in this Report on Form 6-K, including the exhibits hereto, will be made to “qualified institutional buyers” as defined in Rule 144A under the Securities Act or, with respect to institutions or to any existing director or executive officer of the Company only, “accredited investors” as defined in Regulation D under the Securities Act.

EXHIBIT LIST

Exhibit		Description
99.1		~~Press~~Notice ~~release~~of ~~dated~~Extraordinary ~~November~~General 16Meeting, ~~2022,~~including ~~announcing~~Form ~~the~~of ~~contemplated private placement~~Proxy.
99.2		Press release dated November 16, 2022, announcing the completed private placement

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

IDEX BIOMETRICS ASA

Date: November 18, 2022

/s/ Vincent Graziani

Date: November 23, 2022

/s/ Vincent Graziani

Name: Vincent Graziani

Title: Chief Executive Officer

Filing Compare · IDEX Biometrics ASA